Related references
Note: Only part of the references are listed.Ratiometric Activatable Cell-Penetrating Peptides Provide Rapid In Vivo Readout of Thrombin Activation
Michael Whitney et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Multiple Sclerosis: Prospects and Promise
Stephen L. Hauser et al.
ANNALS OF NEUROLOGY (2013)
Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis
Harald F. Langer et al.
CIRCULATION RESEARCH (2012)
In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity
Emilia S. Olson et al.
INTEGRATIVE BIOLOGY (2012)
Thrombin Activity Associated with Neuronal Damage during Acute Focal Ischemia
Bo Chen et al.
JOURNAL OF NEUROSCIENCE (2012)
Fibrinogen as a key regulator of inflammation in disease
Dimitrios Davalos et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation
Dimitrios Davalos et al.
NATURE COMMUNICATIONS (2012)
Parallel in Vivo and in Vitro Selection Using Phage Display Identifies Protease-dependent Tumor-targeting Peptides
Mike Whitney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases
Emilia S. Olson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival
Quyen T. Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain
Eric S. Mullins et al.
BLOOD (2009)
In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer
Emilia S. Olson et al.
INTEGRATIVE BIOLOGY (2009)
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May H. Han et al.
NATURE (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
Christina Marik et al.
BRAIN (2007)
The fibrin-derived γ377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease
Ryan A. Adams et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: Lessons from multiple sclerosis
R. A. Adams et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Thrombin and prothrombin are expressed by neurons and glial cells and accumulate in neurofibrillary tangles in Alzheimer disease brain
T Arai et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
T Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
